MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Measurement of night time sleep using an accelerometry based system

M. Horne, S. McGregor, G. Hamilton, D. O'Driscoll, R. Blaze, P. Churchward (Parkville, Australia)

Meeting: 2016 International Congress

Abstract Number: 368

Keywords: Sleep disorders. See also Restless legs syndrome: Clinical features

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To establish whether accelerometry using the Parkinson Kinetigraph (PKG, Global Kinetics) can distinguish between normal and abnormal nocturnal sleep in Parkinson’s disease (PD).

Background: Nocturnal sleep disturbance is common in PD. A simple effective means of detecting abnormal sleep would aid in identifying those who need further investigation. Polysomnography (PSG) is the gold standard for sleep assessment and uses sleep efficiency (SE), Arousal index, Apnoea Hypopnea Index and Periodic Limb Movements/hr and a report that takes into account these scores. Actigraphy has been widely used but has failed to accurately quantify sleep, in part because of the effect of limb movement during sleep.

Methods: We performed simultaneous PSG and PKG measures in 45 subjects, 10 of whom had normal sleep. The PKG scores “periods of immobility” of at least 2 minutes and we used this to develop, amongst other measures, surrogates for SE (percent of attempted sleep time in which the patient was immobile) and fragmentation (the median length of each period of continuous immobility). These are called %time asleep (%TA) and median time immobile (MTI) respectively. We used these to develop a score that clearly differentiated between normal and abnormal sleepers as determined by the PSG report. We then applied this PKG score to 24 age matched subjects without PD and 35 people with PD (PwP) who wore the PKG for 6 nights and responded to various questionnaires including Parkinson’s disease Sleep Scale 2 (PDSS-2). A further 45 PKG were also analysed but without questionnaire.

Results: The PKG score combining the %TA and the MTI predicted normal or abnormal sleep (according to the PSG) with 100% selectivity and sensitivity. In the 24 subjects without PD only 2 had abnormal sleep according to the PKG and one of these gave a history of restless legs. Amongst the PD subjects 28% had normal sleep according to the PKG criteria and in those interviewed, PKG values had a good correlation (r2 = 0.49) with the PDSS2 scale.

Conclusions: The PKG score appears to provide a simple means of detecting normal and abnormal sleep in PD. This is based on a small PSG sample and further analyses are required.

To cite this abstract in AMA style:

M. Horne, S. McGregor, G. Hamilton, D. O'Driscoll, R. Blaze, P. Churchward. Measurement of night time sleep using an accelerometry based system [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/measurement-of-night-time-sleep-using-an-accelerometry-based-system/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/measurement-of-night-time-sleep-using-an-accelerometry-based-system/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley